Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study.
作者信息
Cai Wen, Cai Biao, Zhou Juan, Chen Yonghui, Zhang Jin, Huang Yiran, Xue Wei, Huang Jiwei
机构信息
Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Rd., Pudong District, Shanghai, 200127, P. R. China.
Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.
出版信息
Cancer Commun (Lond). 2019 Oct 11;39(1):56. doi: 10.1186/s40880-019-0405-5.
Abstract
摘要
Zotero 插件